Literature DB >> 15076631

The incidence of pediatric inflammatory bowel disease in the Netherlands: 1999-2001.

H J van der Zaag-Loonen1, M Casparie, J A J M Taminiau, J C Escher, R Rodrigues Pereira, H H F Derkx.   

Abstract

BACKGROUND: The incidence of inflammatory bowel disease (IBD) seems to be rising. Incidence studies could provide more insight into geographical differences and thereby lead to the identification of etiological factors. The aim of this study was to prospectively assess the incidence of pediatric IBD in the Netherlands from 1999 to 2001, using both an active physician case-reporting registry and a nationwide pathology database.
METHODS: All pediatricians in the Netherlands were sent monthly identification cards to be returned if they had diagnosed a new case of IBD in a pediatric patient. Follow-up questionnaires were sent to physicians reporting new cases of IBD. The pathology database contains reports from all cytologic and histologic diagnoses made in the Netherlands. Two independent raters searched the database for new IBD cases. Cases identified from the pathology database were labeled as "probable IBD" and "possible IBD." Cases were cross-checked across databases on the basis of gender, date of birth, date of biopsy, and place of residence. Age-specific incidence rates were calculated for the Dutch population for the year 2000.
RESULTS: Five hundred forty-six probable cases of IBD were identified; 217 cases were labeled as possible. The incidence rate was 5.2 new cases per 100000 children (<18 years) per year. An increase in incidence with age was observed. Only 24% of the cases were ascertained through the clinical registry.
CONCLUSION: The incidence of IBD cases in the Netherlands is comparable with that reported in other European countries. Epidemiological studies using case reporting by physicians may be underestimates of true incidence rates.

Entities:  

Mesh:

Year:  2004        PMID: 15076631     DOI: 10.1097/00005176-200403000-00014

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  12 in total

1.  Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD.

Authors:  Ying Song; David Dunkin; Stephanie Dahan; Alina Iuga; Clare Ceballos; Kathy Hoffstadter-Thal; Nan Yang; Keith Benkov; Lloyd Mayer; Xiu-Min Li
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

Review 2.  Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

Authors:  A A van Bodegraven; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 3.  Does inflammatory bowel disease develop in infants?

Authors:  Michael D Kappelman; Richard J Grand
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

4.  Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study.

Authors:  Tonya Adamiak; Dorota Walkiewicz-Jedrzejczak; Daryl Fish; Christopher Brown; Jeanne Tung; Khalid Khan; William Faubion; Roger Park; Janice Heikenen; Michael Yaffee; Maria T Rivera-Bennett; Marcy Wiedkamp; Michael Stephens; Richard Noel; Melodee Nugent; Justin Nebel; Pippa Simpson; Michael D Kappelman; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

5.  Neonatal ulcerative colitis associated with Familial Mediterranean fever: a case report.

Authors:  Elif Sag; Ferhat Demir; Mustafa Emre Ercin; Mukaddes Kalyoncu; Murat Cakir
Journal:  Rheumatol Int       Date:  2017-10-13       Impact factor: 2.631

6.  Epidemiology of inflammatory bowel diseases in childhood.

Authors:  M Ravikumara; B K Sandhu
Journal:  Indian J Pediatr       Date:  2006-08       Impact factor: 5.319

7.  Individualized treatment with infliximab therapy in children with Crohn's disease support shorter time intervals between infusions.

Authors:  M Sommar; S Eksborg; H Hildebrand; L Grahnquist
Journal:  J Drug Assess       Date:  2012-01-09

8.  Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015.

Authors:  Jan Schwarz; Josef Sýkora; Dominika Cvalínová; Renáta Pomahačová; Jana Klečková; Martin Kryl; Petr Včelák
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

9.  Sexual Dimorphism in the Response to Broad-spectrum Antibiotics During T Cell-mediated Colitis.

Authors:  Christy A Harrison; Daniel Laubitz; Monica T Midura-Kiela; Deepa R Jamwal; David G Besselsen; Fayez K Ghishan; Pawel R Kiela
Journal:  J Crohns Colitis       Date:  2019-01-01       Impact factor: 9.071

10.  Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example.

Authors:  Gea A Holtman; Yvonne Lisman-van Leeuwen; Boudewijn J Kollen; Johanna C Escher; Angelika Kindermann; Patrick F van Rheenen; Marjolein Y Berger
Journal:  BMC Fam Pract       Date:  2013-11-25       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.